Q1 EPS Forecast for Axsome Therapeutics Lowered by Analyst

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Investment analysts at William Blair decreased their Q1 2025 EPS estimates for Axsome Therapeutics in a research note issued to investors on Tuesday, February 18th. William Blair analyst M. Minter now expects that the company will post earnings per share of ($1.46) for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post Equities Analysts Set Expectations for ANIX Q1 Earnings
Next post Research Analysts Offer Predictions for IRDM Q1 Earnings